A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
BeiGene
Atara Biotherapeutics
Cullinan Therapeutics Inc.
Merck Sharp & Dohme LLC
Tessa Therapeutics
Novartis
Celgene
Sanofi